Bristol-Myers ($BMY) announced the FDA has issued
Post# of 144503
Posted On: 11/30/2015 9:18:15 AM
Bristol-Myers ($BMY) announced the FDA has issued a complete response letter for its sBLA for Opdivo as a single agent to treat previously untreated patients, specifically those with BRAF V600 mutation positive unresectable or metastatic melanoma.
(0)
(0)Scroll down for more posts ▼